Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

The new generation Abbott TriClip G4 device has gained European and Canadian approvals for transcatheter tricuspid valve repair (TTVR).

News | Structural Heart

Abbott Receives CE Mark and Canadian Approval for Next-Generation TriClip Tricuspid Valve Repair Device

April 8, 2021 — Abbott today announced it has received European CE mark and Health Canada authorization this week for ...

April 08, 2021

Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.

News | Stroke

Thrombectomy Market Will Grow With Newly Approved Adjustable Stent Retriever

April 7, 2021 — Market research firm GlobalData's new report, Neurovascular Thrombectomy Devices (Neurology Devices), sh ...

April 07, 2021

COVID-19 disrupted all aspects of science and medicine and unmasked striking disparities and opportunities for transformation. Coronavirus impact this past year is expected to result in a massive rise in new cases of chronic health conditions, including cardiolvascular disease and heart failure.

News | Coronavirus (COVID-19)

Tsunami of Chronic Health Conditions Expected Due to COVID-19 Disruption of Healthcare

April 6, 2021 — A tsunami of chronic health conditions as a result of the COVID-19 (SARS-CoV-2) pandemic, especially car ...

April 07, 2021

The Transmedics Organ Care System (OCS) Heart, or “Heart in a Box,” enables transplant surgeons to travel to much farther destinations to procure transplant hearts by acting as a miniature intensive care unit that keeps the heart alive.

News | Cardiovascular Surgery

Heart in a Box Technology Expands Heart Transplant Window

April 5, 2021 — Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to be ...

April 05, 2021

The new ACC Electrophysiology (EP) Device Implant Registry, part of the National Cardiovascular Data Registry (NCDR) will include data on implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) procedures previously captured in the NCDR ICD Registry, as well as provide the flexibility to capture novel pacemaker procedures. The registry is aligned with the ACC’s Electrophysiology Accreditation program, fully supporting the program’s data requirements.

News | EP Lab

ACC Launches NCDR Electrophysiology Device Implant Registry

April 2, 2021 — Today, the American College of Cardiology (ACC) launched the Electrophysiology (EP) Device Implant ...

April 02, 2021

Videos | Coronavirus (COVID-19)

VIDEO: Antithrombotic Prophylaxis in COVID-19 Patients

Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an ...

April 01, 2021

Sponsored Content | Case Study | Cardiovascular Information Systems (CVIS)

Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...

April 01, 2021

The most popular content this past month included the release of the list of ACC 2021 late-breaking studies, the first AF patients treated with a new pulsed field ablation system, a blog on how the recently FDA cleared coronary lithotripsy balloon system may become a paradigm shift in the cath lab, and the development of engineered tissue valves that can grow with younger patients.

Feature | By Dave Fornell, Editor

April 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

April 01, 2021

The Medtronic Harmony Transcatheter Pulmonary Valve (TPV) System. It is first in the world non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract (RVOT) to stop severe pulmonary valve regurgitation caused by congenital heart disease.

Feature | Structural Heart | By Dave Fornell, Editor

FDA Clears First Device to Treat Right Ventricular Outflow Tract Congenital Heart Disease

March 26, 2021 — Today, the U.S. Food and Drug Administration (FDA) cleared the Medtronic Harmony Transcatheter ...

March 26, 2021

The March April 2021 issue of DAIC, Diagnostic and Interventional Cardiology magazine, Dave Fornell is the editor.

Feature

The DAIC March-April 2021 Digital Edition

View the March-April 2021 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, including links ...

March 26, 2021

Virtual tour views of a University of Colorado cath lab during a CTO procedure (top left), the new robotic EP lab at Banner Health (top right), a bi-plane EP/cath combo lab at Baylor Heart Hospital Dallas (bottom left, and an ECMO procedure at Tufts Medical Center cath lab. Photos by Dave Fornell

Feature

Virtual Tours of Cath and EP Labs

There is a lot of interest in how other hospitals organize and equip their cardiac cath labs and electrophysiology (EP) ...

March 25, 2021

Neonates and young pediatric patients with congenital heart disease have few options for implantable electrophysiology (EP) devices like pacemakers or ICDs.

News | Congenital Heart

Critical Need for Pediatric Electrophysiology Devices is Focus of Medical Device Competition

March 24, 2021 — Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often ...

March 24, 2021

PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.

News | Heart Failure

100th Patient Implanted With Cordella Pulmonary Artery Pressure Sensor For Proactive, Remote Heart Failure Management

March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating of ...

March 24, 2021

Videos | Structural Heart

VIDEO: PFO Closure Shows Continued Stroke Prevention Benefit at 5 Years

Interview with Scott E. Kasner, M.D., who served as the principle investigator for the Gore Cardioform REDUCE trial, and ...

March 23, 2021

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients

Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor

Overview of Trials for Anticoagulation Therapy for COVID-19 Patients

A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...

March 22, 2021